WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.66 Billion | 5.54 Billion | 3.43 Billion | 1.88 Billion | 1.2 Billion | 761.6 Million |
| Net Income | 4.17 Billion | 4.42 Billion | 3.38 Billion | 1.68 Billion | 1.01 Billion | 630.59 Million |
| Depreciation & Amortization | 1.16 Billion | 800.67 Million | 481.78 Million | 303 Million | 221.36 Million | 141.53 Million |
| Deferred income taxes | - | 701.3 Million | 1.64 Billion | 1.82 Billion | 539.59 Million | 430.89 Million |
| Stock-based compensation | 1.27 Billion | 1.23 Billion | 531.92 Million | 276.37 Million | 203.93 Million | 128.37 Million |
| Change in working capital | -896.34 Million | -1.99 Billion | -2.22 Billion | -2.1 Billion | -743.53 Million | -559.26 Million |
| Other non-cash items | -82.88 Million | 320.71 Million | -439 Million | -110.61 Million | -27.09 Million | -10.51 Million |
| Investing Cash Flow | -3.22 Billion | -5.9 Billion | -9.6 Billion | -7.21 Billion | -4.49 Billion | -416.07 Million |
| Investments in PPE | -4.23 Billion | -5.86 Billion | -6.5 Billion | -6.02 Billion | -3.21 Billion | -1.34 Billion |
| Acquisitions | - | -131.48 Million | -2.53 Billion | -155.23 Million | -300.82 Million | -1.27 Billion |
| Investment purchases | -15.08 Billion | -10.77 Billion | -59.3 Billion | -20.35 Billion | -4.64 Billion | -1.05 Billion |
| Sales/Maturities of investments | 15.63 Billion | 10.48 Billion | 58.24 Billion | 19.25 Billion | 3.91 Billion | 2.33 Billion |
| Other Investing Activities | 41.44 Million | 377.56 Million | 497.48 Million | 67.1 Million | -254.53 Million | 924.51 Million |
| Financing Cash Flow | 1.96 Billion | -2.59 Billion | 8.2 Billion | 6.56 Billion | 5.41 Billion | 3.2 Billion |
| Debt repayment | -704.74 Million | -2.68 Billion | -822.11 Million | -349.85 Million | -162.17 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -916.91 Million | -2.8 Billion | -2.51 Billion | - | - | - |
| Common Stock Issuance | 26.15 Million | 36.18 Million | 11.03 Billion | 5.64 Billion | 3.59 Billion | 3.22 Billion |
| Other Financing Activities | 3.89 Billion | 8.31 Billion | 8.2 Billion | 1.26 Billion | 1.97 Billion | -18.63 Million |
| Accounts receivables | -1.03 Billion | -1.49 Billion | -1.44 Billion | -1.4 Billion | -649.52 Million | -463.58 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 442.46 Million | -498.12 Million | -783.18 Million | -704.52 Million | -94 Million | -95.68 Million |
| Other working capital | 178.41 Million | -100.13 Million | -551.77 Million | 4.22 Million | 107.87 Million | -23.83 Million |
| Cash at beginning of period | 6.39 Billion | 9 Billion | 7.09 Billion | 6.2 Billion | 4.08 Billion | 503.88 Million |
| Cash at end of period | 9.66 Billion | 6.39 Billion | 9 Billion | 7.09 Billion | 6.2 Billion | 4.08 Billion |
| Capital Expenditure | -4.23 Billion | -5.86 Billion | -6.5 Billion | -6.02 Billion | -3.21 Billion | -1.34 Billion |
| Effect of forex changes on cash | -125.99 Million | 350.11 Million | -131.5 Million | -340.39 Million | -5.87 Million | 28.15 Million |
| Net cash flow / Change in cash | 3.27 Billion | -2.6 Billion | 1.9 Billion | 890.23 Million | 2.12 Billion | 3.58 Billion |
| Free Cash Flow | 437.19 Million | -326.71 Million | -3.07 Billion | -4.14 Billion | -2 Billion | -578.97 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.49 Billion | 4.17 Billion | 1.13 Billion | 2.26 Billion | 4.42 Billion | 1.88 Billion |
| Depreciation & Amortization | 783.79 Million | 1.16 Billion | - | - | 800.67 Million | 299.71 Million |
| Deferred income taxes | - | - | - | - | 701.3 Million | 1.3 Billion |
| Stock-based compensation | 690.14 Million | 1.27 Billion | 640.8 Million | 782.72 Million | 1.23 Billion | 697.25 Million |
| Change in working capital | - | -896.34 Million | - | - | -1.99 Billion | -2.09 Billion |
| Other non-cash items | -1.67 Billion | -82.88 Million | -1.77 Billion | -3.04 Billion | 320.71 Million | 3.29 Billion |
| Investing Cash Flow | -382.52 Million | -3.22 Billion | - | - | -5.9 Billion | -3.54 Billion |
| Investments in PPE | -1.86 Billion | -4.23 Billion | - | - | -5.86 Billion | -3.18 Billion |
| Acquisitions | - | - | - | - | -131.48 Million | -1.04 Million |
| Investment purchases | - | -15.08 Billion | - | - | -10.77 Billion | - |
| Sales/Maturities of investments | - | 15.63 Billion | - | - | 10.48 Billion | - |
| Other Investing Activities | 1.48 Billion | 41.44 Million | - | - | 377.56 Million | -360.53 Million |
| Financing Cash Flow | -1.47 Billion | 1.96 Billion | - | - | -2.59 Billion | -2.37 Billion |
| Debt repayment | -69.5 Million | -704.74 Million | - | - | -2.68 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.23 Billion | -916.91 Million | - | - | -2.8 Billion | -2.11 Billion |
| Common Stock Issuance | - | 26.15 Million | - | - | 36.18 Million | - |
| Other Financing Activities | -171.68 Million | 3.89 Billion | - | - | 8.31 Billion | -259.25 Million |
| Accounts receivables | - | -1.03 Billion | - | - | -1.49 Billion | -1.49 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | 442.46 Million | - | - | -498.12 Million | -498.12 Million |
| Other working capital | - | 178.41 Million | - | - | -100.13 Million | -100.13 Million |
| Cash at beginning of period | 9.66 Billion | 6.39 Billion | 7.35 Billion | - | 9 Billion | 8.13 Billion |
| Cash at end of period | 9.15 Billion | 9.66 Billion | 7.35 Billion | 782.72 Million | 6.39 Billion | 6.39 Billion |
| Capital Expenditure | -1.86 Billion | -4.23 Billion | - | - | -5.86 Billion | -3.18 Billion |
| Effect of forex changes on cash | 39.67 Million | -125.99 Million | - | - | 350.11 Million | 94.29 Million |
| Net cash flow / Change in cash | -516.31 Million | 3.27 Billion | - | 782.72 Million | -2.6 Billion | -1.74 Billion |
| Free Cash Flow | -565.26 Million | 437.19 Million | - | 782.72 Million | -326.71 Million | 899.86 Million |
3738
NHAWF
PTABF
CLGOF
OTM
AVIV